The present prospective study was planned to explore the mutational status of PIK3CA and AKT1 genes in BC biopsies and matched urines and to assess their use as anon-invasive molecular biomarker for patients ́ diagnosis and monitoring. The gene discussed is PIK3CA; the disease is breast cancer.